Marella Thorell

This profile gathers the share dealings of Marella Thorell across 4 companies, led by Evelo Biosciences, Inc., Centessa Pharmaceuticals plc and GRI BIO, Inc. Over a trading history stretching from 2 June 2021 to 9 October 2025, the count stands at 10 filings.

The open-market side counts 1 purchase for €16k alongside 1 sale. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant and 4 option exercises.

Most recently, on 15 October 2025, the filings show a transaction in ESSA Pharma Inc. The latest purchase dates back some time: it was published 1,962 days ago, on 4 June 2021. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.